Medication info

Dai Dian Duo Tablet 12.5/1000 mg

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Empagliflozin›12.5mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Korea HuTex Pharmaceutical Co., Ltd.
Appearance
Biconvex oval film-coated tablet with a dark brownish-purple color
Packaging
60 tablets/bottle, 60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1]
Approval status
Approval withdrawn

MFDS item code 202302530 · Approved 2023.08.25

This product's status changed to Approval withdrawn on 2026.02.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose is 1 tablet twice daily. The dose of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medications such as insulin, the recommended dose when taking this medication is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medication from concomitant therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medication is coadministered with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medication should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medication, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. No dose adjustment is required for patients with mild renal impairment. Because this medication contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medication is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Administration with Caution in the Following Patients, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medication must be discontinued immediately (see Precautions for Use, 2. Do not administer to the following patients, item 2)). In patients aged 75 years and older, renal function and the risk of volume depletion should be taken into consideration.

Ingredients

Manufacturer
Korea HuTex Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

View approved original text

This medication is used to improve blood glucose control in adult patients with type 2 diabetes when used in conjunction with diet and exercise. It is particularly suitable for patients with type 2 diabetes who do not achieve sufficient blood glucose control, and consultation with a specialist is necessary if there is a history of cardiovascular disease. This medication helps improve the health status of patients by effectively managing blood glucose levels.

How to take

Adult dose

The recommended dose is 1 tablet twice daily. The dose of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medications such as insulin, the recommended dose when taking this medication is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medication from concomitant therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medication is coadministered with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medication should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medication, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. No dose adjustment is required for patients with mild renal impairment. Because this medication contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medication is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Administration with Caution in the Following Patients, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medication must be discontinued immediately (see Precautions for Use, 2. Do not administer to the following patients, item 2)). In patients aged 75 years and older, renal function and the risk of volume depletion should be taken into consideration.

Precautions

This medication is used for the treatment of type 2 diabetes. It should not be used in patients with impaired kidney function or severe kidney disease. Administration should be discontinued in conditions such as acute infections, dehydration, decreased cardiac function, or acute myocardial infarction, and treatment should be paused for a certain period before and after surgery. It is safest not to use this medication in pregnant women or women who may become pregnant, as well as breastfeeding women. When used in conjunction with other medications that lower blood glucose, there may be an increased risk of hypoglycemia, and dosage adjustments may be necessary. Rarely, a serious side effect called lactic acidosis may occur, characterized by excessive buildup of lactic acid in the body, with symptoms including vomiting, abdominal pain, breathing difficulties, lethargy, etc. Additionally, this medication may increase the risk of urinary or genital infections, and immediate consultation with a doctor is required if infection symptoms arise. Long-term use may lower vitamin B12 levels; regular blood tests are recommended to monitor this. This medication may cause dehydration or low blood pressure, so patients, especially the elderly or those at risk of fluid loss, should exercise caution. Alcohol consumption may increase the risk of lactic acidosis, so excessive drinking should be avoided while on this medication. Adequate hydration is important, and patients should be cautious of potential hypoglycemia during irregular meals or vigorous exercise. Regular monitoring of kidney function and blood glucose levels is necessary during the period of medication use. Common side effects include nausea, diarrhea, abdominal pain, hypoglycemia, increased urination, itching, skin rashes, etc. If any abnormal symptoms occur, medical personnel should be notified immediately. This medication is not recommended for children, and dosage adjustments and kidney function monitoring are needed for the elderly. In case of overdose, immediate medical attention should be sought, and blood dialysis may be necessary.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • decrease and deficiency of vitamin B12
  • ketoacidosis
  • lactic acidosis
  • decreased fluid volume
Show 109 more
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
  • abnormal liver function tests
  • hepatitis
  • taste disturbances
  • itching
  • rash
  • hives
  • erythema
  • angioedema
  • dysuria
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • vulvovaginitis
  • vulvitis
  • balanitis
  • perineal necrosis
  • increased serum creatinine
  • decreased glomerular filtration rate
  • chronic gastritis
  • various gastrointestinal disorders
  • cerebral infarction
  • soft tissue infection
  • pneumonia
  • ankle fracture
  • epicondylitis
  • facial bone fracture
  • musculoskeletal pain
  • myocardial infarction
  • ketoacidosis
  • urinary sepsis
  • pyelonephritis
  • rash
  • hives
  • angioedema
  • perineal necrosis
  • chronic gastritis
  • constipation
  • gastritis
  • abdominal discomfort
  • anal incontinence
  • dry mouth
  • gastrointestinal disorders
  • oral discomfort
  • salivary gland pain
  • cerebral infarction
  • headache
  • sensory impairment
  • positional dizziness
  • dizziness
  • cerebral infarction
  • headache
  • positional dizziness
  • hypercholesterolemia
  • dyslipidemia
  • vitamin D deficiency
  • nasopharyngitis
  • soft tissue infection
  • pneumonia
  • upper respiratory tract infection
  • asthenia
  • chest discomfort
  • chest pain
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • weight loss
  • urinary stones
  • vulvar pruritus
  • benign prostatic hyperplasia
  • diabetic retinopathy
  • diplopia
  • hypertension
  • insomnia
  • dizziness
  • constipation
  • diarrhea
  • dyspepsia
  • abdominal pain
  • nausea
  • gastritis
  • gastrointestinal disorders
  • nasopharyngitis
  • herpes zoster
  • headache
  • chest discomfort
  • chest pain
  • asthenia
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • hyperglycemia
  • back pain
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • unstable angina
  • hypertension
  • anxiety

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and the storage temperature should be maintained at room temperature, between 1 degree to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

Biconvex oval film-coated tablet with a dark brownish-purple color

Package unit

60 tablets/bottle, 60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.